UC Surgeons Perform Breakthrough Robotic Liver Surgery
Mark Thomas, MD, and Joseph Buell, MD, both transplant surgeons at UC, performed the operation on a 56-year-old man on Sept. 18 at
This patient had a bile-duct tumor in the left lobe of his liver that affected the organs function. Although the surgical team had to remove about 30 percent of his liver, the patient is doing well and is expected to fully recover.
Robotic surgery is a method of operating inside the abdomen using robotic arms and specialized instruments inserted through small incisions (about half an inch each) into the body. A surgeon controls these arms from behind a computer console several feet away from the patient.
Robotic liver surgery is a sophisticated way to do an old surgery that benefits both the patient and the surgeons, says Thomas, an assistant professor surgery at UC.
The robotic arms essentially become an extension of the surgeons own hands and arms, he adds, but with the benefit of a 360-degree range of motion thats not possible with traditional laparoscopic (minimally invasive) methods.
The robotic approach, he says, provides better depth perception and fine-motion control inside the abdomen compared with traditional methods, which allows the surgeon to operate with greater precision and control suturing techniques.
Robotic surgery extends the surgeons capabilities and makes the operation feel like open surgery without the need for a major incision into the abdomen, adds Buell, an associate professor of surgery at UC. That means the patient experiences less post-surgery pain and recovers faster.
UC surgeons say the procedure is a safe, effective alternative to traditional open surgery for advanced liver disease and liver cancerwhich requires up to a 30-inch incision.
The liver, one of the bodys largest organs, helps metabolize food and medicine that the blood absorbs from the intestines, produces bile to help digest fats, and stores energy-producing glycogen (sugar).
To perform the robotic liver procedure, carbon dioxide is pumped into the patients abdomen to increase the operative area and improve the surgeons view of the tumor. The surgeon then makes two to four small incisions to accommodate the robotic arms, a laparoscope (a tiny telescope equipped with a camera), and other specialized surgical instruments. The surgeon then severs and ties off the tumors blood supply, cuts out the tumor itself, places it inside a sealed bag, and removes it through one of the incisions.
The liver is a self-healing organ, explains Thomas, so once the tumor is removed, the area typically heals within two to four weeks.
Together, Thomas and Buell perform about 250 laparoscopic liver cases a year. According to Intuitive Surgical, maker of the da Vinci system, this is only the 42nd robotic laparoscopic liver resection surgery performed in the
The bottom line is that robotic surgery is an advantage for our patientsit results in less pain and faster recovery time, says Buell. We need to modify and grow this technology so we can provide the same advanced care to people in remote places.
For more information on minimally invasive liver surgery at UC, visit www.lapliver.com.
Mark Thomas, MD, (right) assists during a robotic liver surgery.
Mark Thomas, MD, is an assistant professor and transplant surgeon at UC.
Tags
Related Stories
Make Hoxworth Blood Center’s special holiday events part of your family celebrations this December
December 12, 2025
This December, Hoxworth Blood Center, University of Cincinnati, is inviting families across Greater Cincinnati to add something truly meaningful to their holiday traditions: giving the gift of life. With festive community events, beloved local partners and special thank-you gifts for donors, Hoxworth is making it easier, and more heartwarming than ever, to roll up your sleeves and help save lives close to home.
Ohio nurses weigh in on proposed federal loan rule
December 12, 2025
Spectrum News journalist Javari Burnett spoke with UC Dean Alicia Ribar and UC nursing students Megan Romero and Nevaeh Haskins about proposed new federal student loan rules. Romero and Haskins, both seniors, were filmed in the College of Nursing’s Simulation Lab.
New combination treatment improves multiple myeloma outcomes
December 11, 2025
The University of Cincinnati Cancer Center's Ed Faber, DO, provided commentary to Medscape on the COBRA study that found the combination of carfilzomib combined with lenalidomide and dexamethasone (KRd) shows significantly greater efficacy than the previous standard of care.